Despite the past year's reactor shutdown turmoil, Canadian healthcare company MDS and its radioisotope developer MDS Nordion of Kanata, Ontario, posted revenue increases for its second quarter 2008 (end-April 30).
MDS reported total revenue of $350 million, up 28% compared to $273 million for the same period in 2007.
For the period, MDS Nordion delivered revenue of $80 million, up 13% from $71 million in the prior year.
Related Reading
SNM explores feasibility of U.S. medical isotope source, May 22, 2008
Canadian government to stop development of Maple reactors, May 16, 2008
New York hedge fund attempts to split MDS, April 11, 2008
Reactor shutdown hurts MDS Nordion's Q1, March 6, 2008
MDS expects less impact from reactor shutdown, December 17, 2007
Copyright © 2008 AuntMinnie.com
